Zhe Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhe Gao has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Juan Du
School of Medicine and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People’s Republic of China
2 shared publications Ruixi Li
2 shared publicationsTingzhou Zhao
School of Medicine and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
2 shared publicationsBo Wang
School of Medicine and Life Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publicationChao Liu
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publicationDan Luo
School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
1 shared publication
Latest Publications
- Open Access
- 17 December 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1710291
Bibliometric analysis of trends, innovations, and the future of CBT-based mobile interventions for depression
Background: Depression is a major global health challenge, and traditional cognitive behavioral therapy (CBT) is constrained by therapist shortages and economic barriers. CBT-based mobile applications offer a scalable and accessible alternative, yet a comprehensive overview of their global research landscape remains limited. Objective: To map global research trends, clinical progress, and emerging frontiers in CBT-based mobile applications for depression using bibliometric methods. Methods: Relevant studies were systematically retrieved from the Web of Science Core Collection, PubMed, and PsycINFO from inception to June 25, 2025. CiteSpace 6.4 R1, Microsoft Excel 2019, and Python were used for visualization and data analysis, including temporal publication trends, co-authorship, co-citation, keyword analyses, and citation burst detection. Results: The WoSCC analysis identified 350 articles published between 2013 and 2025, showing a marked growth trajectory with leading contributions from the United States and major academic centers. Dominant themes included smartphone interventions, blended treatments, CBT for insomnia, and adolescent depression, while citation bursts indicated recent shifts toward prevention, technology integration, and standardized outcome measures. The PubMed analysis included 72 clinical trial articles, highlighting randomized controlled trials as the predominant design and revealing growing interest in integrating interpersonal therapy and mindfulness within broader, interdisciplinary treatment frameworks. The PsycINFO analysis comprised 20 articles and provided a complementary behavioral science perspective, emphasizing mobile phone–delivered CBT for major depression, digital interventions targeting comorbid social anxiety, culturally adapted applications for Chinese cultural groups, and emerging work linking mobile health and virtual reality. Conclusions: Research on CBT-based mobile applications for depression is rapidly advancing toward more personalized, adaptive, and preventive digital interventions grounded in robust clinical and behavioral evidence. Strengthening global, interdisciplinary collaboration and leveraging innovative technologies will be critical for translating these tools into effective, scalable services. Over the next 5–10 years, key research streams are likely to include the integration of Artificial Intelligence (AI) and large language models (LLMs) into mobile CBT platforms and the convergence of app-based interventions with sensor-based digital phenotyping, wearable devices, and immersive technologies to enhance real-time monitoring, user engagement, and long-term outcomes, with the potential to narrow treatment gaps across diverse populations. Systematic review registration: https://osf.io/ , Identifier: https://doi.org/10.17605/OSF.IO/YCSR8 .
- 17 December 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1710291
Open AccessBibliometric analysis of trends, innovations, and the future of CBT-based mobile interventions for depression
Background: Depression is a major global health challenge, and traditional cognitive behavioral therapy (CBT) is constrained by therapist shortages and economic barriers. CBT-based mobile applications offer a scalable and accessible alternative, yet a comprehensive overview of their global research landscape remains limited. Objective: To map global research trends, clinical progress, and emerging frontiers in CBT-based mobile applications for depression using bibliometric methods. Methods: Relevant studies were systematically retrieved from the Web of Science Core Collection, PubMed, and PsycINFO from inception to June 25, 2025. CiteSpace 6.4 R1, Microsoft Excel 2019, and Python were used for visualization and data analysis, including temporal publication trends, co-authorship, co-citation, keyword analyses, and citation burst detection. Results: The WoSCC analysis identified 350 articles published between 2013 and 2025, showing a marked growth trajectory with leading contributions from the United States and major academic centers. Dominant themes included smartphone interventions, blended treatments, CBT for insomnia, and adolescent depression, while citation bursts indicated recent shifts toward prevention, technology integration, and standardized outcome measures. The PubMed analysis included 72 clinical trial articles, highlighting randomized controlled trials as the predominant design and revealing growing interest in integrating interpersonal therapy and mindfulness within broader, interdisciplinary treatment frameworks. The PsycINFO analysis comprised 20 articles and provided a complementary behavioral science perspective, emphasizing mobile phone–delivered CBT for major depression, digital interventions targeting comorbid social anxiety, culturally adapted applications for Chinese cultural groups, and emerging work linking mobile health and virtual reality. Conclusions: Research on CBT-based mobile applications for depression is rapidly advancing toward more personalized, adaptive, and preventive digital interventions grounded in robust clinical and behavioral evidence. Strengthening global, interdisciplinary collaboration and leveraging innovative technologies will be critical for translating these tools into effective, scalable services. Over the next 5–10 years, key research streams are likely to include the integration of Artificial Intelligence (AI) and large language models (LLMs) into mobile CBT platforms and the convergence of app-based interventions with sensor-based digital phenotyping, wearable devices, and immersive technologies to enhance real-time monitoring, user engagement, and long-term outcomes, with the potential to narrow treatment gaps across diverse populations. Systematic review registration: https://osf.io/ , Identifier: https://doi.org/10.17605/OSF.IO/YCSR8 .
- Open Access
- 10 September 2025
- Published by Frontiers Media SA in Frontiers in Medicine
Erastin-induced multi-pathway cell death in endometriosis: a mechanistic and translational narrative review
This narrative review examines the therapeutic potential of Erastin and its derivatives for endometriosis (EMS) by integrating mechanistic, preclinical, and translational perspectives. We conducted a focused review of literature from PubMed and Web of Science Core Collection (WoSCC) through August 2025; following a systematic screening and de-duplication process, 91 studies were included for synthesis. The evidence indicates that within the iron-rich, ROS-prone microenvironment of EMS, Erastin inhibits the system Xc− transporter, depletes intracellular glutathione (GSH), and inactivates GPX4, thereby driving ferroptosis in ectopic endometrial stromal cells. This process engages a coordinated network of regulated cell death that extends beyond ferroptosis to include crosstalk with necroptosis and pyroptosis, while being critically modulated by ferritinophagy and the paradoxical role of defective mitophagy. Despite the development of next-generation analogs with improved pharmacological properties, clinical translation is constrained by a narrow therapeutic window due to on-target and off-target toxicities. To overcome these limitations, we propose that future strategies must prioritize lesion-focused drug delivery, such as nanocarriers and triggerable prodrugs, alongside biomarker-guided treatment regimens to decouple efficacy from systemic risk, paving a credible path for the clinical application of Erastin-class agents in EMS.
- 10 September 2025
- Published by Frontiers Media SA in Frontiers in Medicine
Open AccessErastin-induced multi-pathway cell death in endometriosis: a mechanistic and translational narrative review
This narrative review examines the therapeutic potential of Erastin and its derivatives for endometriosis (EMS) by integrating mechanistic, preclinical, and translational perspectives. We conducted a focused review of literature from PubMed and Web of Science Core Collection (WoSCC) through August 2025; following a systematic screening and de-duplication process, 91 studies were included for synthesis. The evidence indicates that within the iron-rich, ROS-prone microenvironment of EMS, Erastin inhibits the system Xc− transporter, depletes intracellular glutathione (GSH), and inactivates GPX4, thereby driving ferroptosis in ectopic endometrial stromal cells. This process engages a coordinated network of regulated cell death that extends beyond ferroptosis to include crosstalk with necroptosis and pyroptosis, while being critically modulated by ferritinophagy and the paradoxical role of defective mitophagy. Despite the development of next-generation analogs with improved pharmacological properties, clinical translation is constrained by a narrow therapeutic window due to on-target and off-target toxicities. To overcome these limitations, we propose that future strategies must prioritize lesion-focused drug delivery, such as nanocarriers and triggerable prodrugs, alongside biomarker-guided treatment regimens to decouple efficacy from systemic risk, paving a credible path for the clinical application of Erastin-class agents in EMS.
- Open Access
- 12 May 2025
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 64 (3) , 580
Comments on “The timing for embryo transfer after antibiotic therapy for chronic endometritis”
- 12 May 2025
- Published by Elsevier in Taiwanese Journal of Obstetrics and Gynecology
- Vol. 64 (3) , 580
Open AccessComments on “The timing for embryo transfer after antibiotic therapy for chronic endometritis”
- 5 May 2025
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 54 (7) , 102966
Deciphering the dualities of robotic hysterectomy in endometrial cancer: Toward personalized approaches and AI-driven insights
- 5 May 2025
- Published by Elsevier in Journal of Gynecology Obstetrics and Human Reproduction
- Vol. 54 (7) , 102966
Deciphering the dualities of robotic hysterectomy in endometrial cancer: Toward personalized approaches and AI-driven insights
- Open Access
- 23 April 2025
- Published by Elsevier in Asian Journal of Surgery
Does robotic assistance improve outcomes in ureteral reimplantation for endometriosis?
- 23 April 2025
- Published by Elsevier in Asian Journal of Surgery
Open AccessDoes robotic assistance improve outcomes in ureteral reimplantation for endometriosis?
- Open Access
- 8 March 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1372527
The anti-cholestatic effects of Coptis chinensis Franch. alone and combined with Tetradium ruticarpum (A. Jussieu) T. G. Hartley: dual effects on fecal metabolism and microbial diversity
Introduction: Drug dosages and combinations are the main factors that affect the efficacy of pleiotropic traditional Chinese medicine (TCM). Coptis chinensis Franch. (CF) is a representative TCM with multiple effects and is often combined with Tetradium ruticarpum (A. Jussieu) T. G. Hartley (TR) to treat cholestasis. The present study assessed the influence of CF dose and its combination with TR on the efficacy of CF in cholestasis treatment, including their effects on fecal metabolism and fecal microorganisms.Methods: Rats with α-naphthylisothiocyanate (ANIT, 50 mg/kg)-induced cholestasis were administered low (0.3 g/kg) and high (0.6 g/kg) doses of CF, as well as CF combined with TR at doses of 0.6 g/kg and 0.9 g/kg, respectively. The anti-cholestatic effects of these treatments were assessed by determining their anti-inflammatory, hypolipidemic, and anti-oxidative stress properties. Additionally, fecal metabolomics and fecal microorganisms were analyzed.Results: Low dose CF had a more potent hypolipidemic effect than high dose CF, whereas high dose CF had more potent anti-inflammatory and anti-oxidative stress effects. Combination with TR enhanced the hypolipidemic effect, but antagonized the anti-inflammatory effect, of CF. Analyses of fecal metabolomics and fecal microorganisms showed differences in the regulation of lipid- and amino acid metabolism-related pathways, including pathways of linoleic acid, tyrosine, and arachidonic acid metabolism, and amino acid biosynthesis between different doses of CF as well as between different doses of CF in combination with TR. These differences may contribute to differences in the anti-cholestatic effects of these preparations.Conclusion: CF dose influences its anti-cholestatic efficacy. The combination with TR had synergistic or antagonistic effects on the properties of CF, perhaps by altering fecal metabolism and fecal microbial homeostasis.
- 8 March 2024
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1372527
Open AccessThe anti-cholestatic effects of Coptis chinensis Franch. alone and combined with Tetradium ruticarpum (A. Jussieu) T. G. Hartley: dual effects on fecal metabolism and microbial diversity
Introduction: Drug dosages and combinations are the main factors that affect the efficacy of pleiotropic traditional Chinese medicine (TCM). Coptis chinensis Franch. (CF) is a representative TCM with multiple effects and is often combined with Tetradium ruticarpum (A. Jussieu) T. G. Hartley (TR) to treat cholestasis. The present study assessed the influence of CF dose and its combination with TR on the efficacy of CF in cholestasis treatment, including their effects on fecal metabolism and fecal microorganisms.Methods: Rats with α-naphthylisothiocyanate (ANIT, 50 mg/kg)-induced cholestasis were administered low (0.3 g/kg) and high (0.6 g/kg) doses of CF, as well as CF combined with TR at doses of 0.6 g/kg and 0.9 g/kg, respectively. The anti-cholestatic effects of these treatments were assessed by determining their anti-inflammatory, hypolipidemic, and anti-oxidative stress properties. Additionally, fecal metabolomics and fecal microorganisms were analyzed.Results: Low dose CF had a more potent hypolipidemic effect than high dose CF, whereas high dose CF had more potent anti-inflammatory and anti-oxidative stress effects. Combination with TR enhanced the hypolipidemic effect, but antagonized the anti-inflammatory effect, of CF. Analyses of fecal metabolomics and fecal microorganisms showed differences in the regulation of lipid- and amino acid metabolism-related pathways, including pathways of linoleic acid, tyrosine, and arachidonic acid metabolism, and amino acid biosynthesis between different doses of CF as well as between different doses of CF in combination with TR. These differences may contribute to differences in the anti-cholestatic effects of these preparations.Conclusion: CF dose influences its anti-cholestatic efficacy. The combination with TR had synergistic or antagonistic effects on the properties of CF, perhaps by altering fecal metabolism and fecal microbial homeostasis.
- Open Access
- 1 January 2024
- Published by Clausius Scientific Press, Inc. in Applied & Educational Psychology
- Vol. 5 (6) , 132-140
Factors Influencing Generalized Anxiety Disorder Prevalence among Chinese University Students: A Case Study of a Medical University
The aim of this study is to investigate the prevalence of Generalized Anxiety Disorder (GAD) among students at a medical university in China and to analyze the associations between GAD and factors related to their basic characteristics and sleep situation. The method applied in this paper is a stratified cluster random sampling method used to select on-campus students aged ≥18. An improved questionnaire based on the Generalized Anxiety Disorder 7-item (GAD-7) scale is utilized to screen for tendencies toward GAD. This study also examines the influence of student habits, including late bedtime and sleep-related factors. The findings indicate that approximately 6.437% of respondents exhibit a tendency toward GAD. Significant correlations are identified between GAD and variables such as medical-related majors, family function, academic pressure, emotional issues, and late bedtime, which includes average sleep duration, tendency to late bedtime, and sleep quality (P0.05). The results suggest that college students, as a special population, have a higher prevalence rate of GAD compared to the general incidence reported in other countries and regions. A subset of students at the medical university exhibits a tendency toward GAD, which is associated with factors such as family function, medical-related majors, and sleep.
- 1 January 2024
- Published by Clausius Scientific Press, Inc. in Applied & Educational Psychology
- Vol. 5 (6) , 132-140
Open AccessFactors Influencing Generalized Anxiety Disorder Prevalence among Chinese University Students: A Case Study of a Medical University
The aim of this study is to investigate the prevalence of Generalized Anxiety Disorder (GAD) among students at a medical university in China and to analyze the associations between GAD and factors related to their basic characteristics and sleep situation. The method applied in this paper is a stratified cluster random sampling method used to select on-campus students aged ≥18. An improved questionnaire based on the Generalized Anxiety Disorder 7-item (GAD-7) scale is utilized to screen for tendencies toward GAD. This study also examines the influence of student habits, including late bedtime and sleep-related factors. The findings indicate that approximately 6.437% of respondents exhibit a tendency toward GAD. Significant correlations are identified between GAD and variables such as medical-related majors, family function, academic pressure, emotional issues, and late bedtime, which includes average sleep duration, tendency to late bedtime, and sleep quality (P0.05). The results suggest that college students, as a special population, have a higher prevalence rate of GAD compared to the general incidence reported in other countries and regions. A subset of students at the medical university exhibits a tendency toward GAD, which is associated with factors such as family function, medical-related majors, and sleep.